ACRO BIOMEDICAL CO., LTD.
Income Statement
| Line Item | FY2017 |
|---|---|
| Revenue | $510.0K |
| Cost of Revenue | $459.0K |
| Gross Profit | $51.0K |
| Gross Margin | 10.0% |
| Operating Expenses | |
| Research & Development | — |
| SG&A Expense | $53.2K |
| Operating Income | $-2.2K |
| Operating Margin | -0.4% |
| Interest Expense | — |
| Pretax Income | $-2.2K |
| Income Tax Expense | $0 |
| Net Income | $-2.2K |
| Net Margin | -0.4% |
| EPS (Basic) | $0.00 |
| EPS (Diluted) | $0.00 |
| Shares Outstanding (Basic) | 47.7M |
| Shares Outstanding (Diluted) | 47.7M |
| Dividends Per Share | — |